| The Heritage Rehabilitation And Health Care Center | |
| 5606 15th Ave, Brooklyn, New York 11219 | |
| (718) 851-1000 | |
| Name | The Heritage Rehabilitation And Health Care Center |
|---|---|
| Location | 5606 15th Ave, Brooklyn, New York |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 79 |
| Occupancy Rate | 82.78% |
| Medicare ID (CCN) | 335104 |
| Legal Business Name | Palm Tree Care Center Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1124299128 |
| Organization Name | PALM TREE CARE CENTER LLC |
| Address | 5606 15th Ave, Brooklyn, NY 11219 |
| Phone Number | 718-851-1000 |
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) have been awarded nearly $1 million to investigate Adenovirus-36 (Ad-36) infection as a novel risk factor for obesity.
The commissioner of the Food and Drug Administration questions whether the right financial incentives are in place for drugmakers who develop orphan drugs for rare diseases.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.
A new study published in Investigative Ophthalmology & Visual Science has found that chronic (long term) hypertension increases a person's susceptibility to glaucoma. These results suggest that doctors should consider a patient's blood pressure levels in managing the potentially blinding eye disorder.
› Verified 2 days ago
| NPI Number | 1366489593 |
| Organization Name | THE PALM TREE CENTER FRO NURSING AND REHABILITATION |
| Address | 5606 15th Ave, Brooklyn, NY 11219 |
| Phone Number | 718-851-1000 |
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) have been awarded nearly $1 million to investigate Adenovirus-36 (Ad-36) infection as a novel risk factor for obesity.
The commissioner of the Food and Drug Administration questions whether the right financial incentives are in place for drugmakers who develop orphan drugs for rare diseases.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.
A new study published in Investigative Ophthalmology & Visual Science has found that chronic (long term) hypertension increases a person's susceptibility to glaucoma. These results suggest that doctors should consider a patient's blood pressure levels in managing the potentially blinding eye disorder.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) have been awarded nearly $1 million to investigate Adenovirus-36 (Ad-36) infection as a novel risk factor for obesity.
The commissioner of the Food and Drug Administration questions whether the right financial incentives are in place for drugmakers who develop orphan drugs for rare diseases.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.
A new study published in Investigative Ophthalmology & Visual Science has found that chronic (long term) hypertension increases a person's susceptibility to glaucoma. These results suggest that doctors should consider a patient's blood pressure levels in managing the potentially blinding eye disorder.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.01 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.78 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 42.42 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.51 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 8.12 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 72.95 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 17.03 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.18 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.56 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 19.02 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 69.92 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.92 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.18 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.39 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 19.74 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.52 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 85.31 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 74.9 | 82.93 |
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) have been awarded nearly $1 million to investigate Adenovirus-36 (Ad-36) infection as a novel risk factor for obesity.
The commissioner of the Food and Drug Administration questions whether the right financial incentives are in place for drugmakers who develop orphan drugs for rare diseases.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.
A new study published in Investigative Ophthalmology & Visual Science has found that chronic (long term) hypertension increases a person's susceptibility to glaucoma. These results suggest that doctors should consider a patient's blood pressure levels in managing the potentially blinding eye disorder.
› Verified 2 days ago
Brooklyn Gardens Nursing & Rehabilitation Center Location: 835 Herkimer Street, Brooklyn, New York 11233 Phone: (718) 221-2600 | |
The Heritage Rehabilitation And Health Care Center Location: 5606 15th Ave, Brooklyn, New York 11219 Phone: (718) 851-1000 | |
Spring Creek Rehabilitation & Nursing Care Center Location: 660 Louisiana Ave, Brooklyn, New York 11239 Phone: (718) 669-7100 | |
New Carlton Rehab And Nursing Center, L L C Location: 405 Carlton Ave, Brooklyn, New York 11238 Phone: (718) 789-6262 | |
Cobble Hill Health Center Inc Location: 380 Henry Street, Brooklyn, New York 11201 Phone: (718) 855-6789 |